Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Recent Advances in Anti-Infective Drug Discovery
  4. Fast Track Articles
  5. Fast Track Article
image of Comprehensive Review on Tinea Infection Therapies: Allopathic and Herbal Approaches for Dermatophytosis

Abstract

Background

Tinea infections are superficial fungal infections caused by three species of fungi ( Epidermophyton, Microsporum, and Trichophyton) collectively termed dermatophytes. Dermatophytes are fungi that cause skin, nail bed, and hair infections. These infections are classified based on infection site, including tinea pedis (foot), tinea corporis (body), tinea capitis (head), and tinea cruris (groin). Dermatophytes can spread by direct contact with other people (anthropophilic organisms), animals (zoophilic organisms), and soil (geophilic organisms), as well as indirectly from fomities.

Objective

This review aims to summarize the allopathic drugs along with their mechanism of action and herbal drugs including their parts of the plant used for the treatment of tinea infections.

Methods

The literature review was performed using the following databases: PubMed (https://pubmed.ncbi.nlm.nih.gov/), and Google Scholar (https://scholar.google.com/), to identify the various drugs involved in the treatment of dermatophytosis along with their mechanisms. Results:

The following keywords were applied in the search strategy: “”, “Dermatophytosis”, “Ringworm infection”, “Pathogenesis of tinea”, “”, and “”. This article also reviews several formulations that are available in the market for treating ringworm infection.

Conclusion

The current review provides information about the classification of dermatophytosis based on infection site and environmental habitat, pathogenesis, immunopathogenesis of dermatophytes, and herbals and allopathic drugs used for their treatment.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/raaidd/10.2174/0127724344305611241113174748
2025-01-03
2025-07-11

  • From This Site

    /content/journals/raaidd/10.2174/0127724344305611241113174748
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. The World health report: 2004: Changing history. Available from: https://iris.who.int/bitstream/handle/10665/42891/924156265X.pdf 2004
  2. Martin A.G. Kobayashi G.S. Superficial fungal infection. Fitzpatrick's Dermatology in General Medicine McGraw Hill 1999 2337 2357
    [Google Scholar]
  3. Watkins J. Symptoms and treatment of ringworm infections. Br. J. School Nurs. 2014 9 3
    [Google Scholar]
  4. Gupta B.K. Kumar S. Kumar R.A. Khurana S. Mycological aspects of dermatomycosis in Ludhiana. Indian J. Pathol. Microbiol. 1993 36 3 233 237 8300168
    [Google Scholar]
  5. Patwardhan N. Dave R. Dermatomycosis in and around Aurangabad. Indian J. Pathol. Microbiol. 1999 42 4 455 462 11127378
    [Google Scholar]
  6. Jain N. Sharma M. Saxena V.N. Clinico-mycological profile of dermatophytosis in Jaipur, Rajasthan. Indian J. Dermatol. Venereol. Leprol. 2008 74 3 274 275 10.4103/0378‑6323.41388 18583809
    [Google Scholar]
  7. Sharma M. Sharma R. Profile of dermatophytic and other fungal infections in jaipur. Indian J. Microbiol. 2012 52 2 270 274 10.1007/s12088‑011‑0217‑z 23729893
    [Google Scholar]
  8. Meghana T. Sailaja A.K. Herbal antifungal agents used for the treatment of fungal infections. Clin. Case Rep. Clin. Study 1 1 2021
    [Google Scholar]
  9. Gruby D. Memory on a vegetation which constitutes the real ringworm. CR Acad. Sci. 1841 13 72 75
    [Google Scholar]
  10. Gruby D. On the mycoderms which constitute the ringworm. CR Acad. Sci 1841 13 309 312
    [Google Scholar]
  11. Gruby D. Research on the nature, location and development of Porrigo decalvans or Phytoalopecia. CR Acad Sci. 1843 17 301 302
    [Google Scholar]
  12. Gruby D. Research on cryptogams which constitute the contagious disease of the scalp described under the name Tinea tondante (Mahon), Herpes tonsurans (Cazenave). CR Acad. Sci 1844 18 583 585
    [Google Scholar]
  13. Odds F.C. Sabouraud('s) agar. Med. Mycol. 1991 29 6 355 359 10.1080/02681219180000581 1815027
    [Google Scholar]
  14. Kwon-Chung K.J. Bennett J.E. Medical mycology. Rev. Inst. Med. Trop. São Paulo 1992 34 6 504 10.1590/S0036‑46651992000600018
    [Google Scholar]
  15. Emmons C.W. Dermatophytes: Natural grouping based on the form of the spores and accessory organs. Arch. Derm. Syphilol. 1934 30 3 337 362 10.1001/archderm.1934.01460150003001
    [Google Scholar]
  16. Benham R.W. Nutritional studies of the dermatophytes; Effect on growth and morphology, with special reference to the production of macroconidia. Trans. N. Y. Acad. Sci. 1953 15 4 Series II 102 106 10.1111/j.2164‑0947.1953.tb00327.x 13038984
    [Google Scholar]
  17. Silva M. Benham R.W. Nutritional studies of the dermatophytes with special reference to Trichophyton Megnini Blanchard 1896 and Trichophyton gallinae (Megnin 1881) comb. Nov. J. Invest. Dermatol. 1952 18 6 453 472 10.1038/jid.1952.55 14938662
    [Google Scholar]
  18. Ajello L. Georg L.K. In vitro hair cultures for differentiating between atypical isolates of Trichophyton mentagrophytes and Trichophyton rubrum. Mycopathologia 1957 8 1 3 17 10.1007/BF02053114 13430694
    [Google Scholar]
  19. Georg L.K. Cultural and nutritional studies of richophyton gallinae and Trichophyton megnini. Mycologia 1952 44 4 470 492 10.1080/00275514.1952.12024210
    [Google Scholar]
  20. Georg L.K. Camp L.B. Routine nutritional tests for the identification of dermatophytes. J. Bacteriol. 1957 74 2 113 121 10.1128/jb.74.2.113‑121.1957 13475205
    [Google Scholar]
  21. Swartz H.E. Georg L.K. The nutrition of Trichophyton tonsurans. Mycologia 47 4 475 493 1955 10.1080/00275514.1955.12024470
    [Google Scholar]
  22. Dawson C.O. Gentles J.C. Addendum toThe perfect states of Keratinomyces ajelloi Vanbreuseghem, Trichophyton terrestre Dune & Frey and Microsporum nanum Fuentes’. Sabouraudia 1961 1 2
    [Google Scholar]
  23. Vanbreuseghem R. Biological technique for isolating dermatophytes from soil. Ann. Soc. Belg. Med. Trop. 1952 32 2 173 178 14953089
    [Google Scholar]
  24. Griffin D.M. The re-discovery of Gymnoascus gypseum, the perfect state of Microsporum gypseum, and a note on Trichophyton terrestre. Trans. Br. Mycol. Soc. 1960 43 4 637 IN6 10.1016/S0007‑1536(60)80054‑X
    [Google Scholar]
  25. Stockdale P.M. Nannizzia incurvata gen. nov., sp. nov., A perfect state of Microsporum gypseum (Bodin) Guiart et Grigorakis. Med. Mycol. 1962 1 1 41 48 10.1080/00362176285190101
    [Google Scholar]
  26. Stockdale P.M. The Microsporum gypseum complex ( Nannizzia incurvata Stockd., N. gypsea (Nann.) comb. nov., N. fulva sp. nov.). Med. Mycol. 1964 3 1 114 126 10.1080/00362176485190161 5896180
    [Google Scholar]
  27. Weitzman I. Variation in Microsporum gypseum. I. A genetic study of pleomorphism. Med. Mycol. 1964 3 3 195 204 10.1080/00362176485190341 5896099
    [Google Scholar]
  28. Weitzman I. Incompatibility in the Microsporum gypseum complex. Mycologia 56 3 425 435 1964 10.1080/00275514.1964.12018127
    [Google Scholar]
  29. Gentles J.C. Experimental ringworm in guinea pigs: Oral treatment with griseofulvin. Nature 1958 182 4633 476 477 10.1038/182476a0 13577889
    [Google Scholar]
  30. Bressani V.O. Santi T.N. Domingues-Ferreira M. Almeida A. Duarte A.J.S. Moraes-Vasconcelos D. Characterization of the cellular immunity in patients presenting extensive dermatophytoses due to Trichophyton rubrum. Mycoses 2013 56 3 281 288 10.1111/myc.12018 23145831
    [Google Scholar]
  31. Brasch J. Current knowledge of host response in human tinea. Mycoses 2009 52 4 304 312 10.1111/j.1439‑0507.2008.01667.x 19207841
    [Google Scholar]
  32. Samanta I. Veterinary Mycology Springer New Delhi 2015 10.1007/978‑81‑322‑2280‑4
    [Google Scholar]
  33. Zurita J. Hay R.J. Adherence of dermatophyte microconidia and arthroconidia to human keratinocytes in vitro. J. Invest. Dermatol. 1987 89 5 529 534 10.1111/1523‑1747.ep12461067 3668298
    [Google Scholar]
  34. Vermout S. Tabart J. Baldo A. Mathy A. Losson B. Mignon B. Pathogenesis of dermatophytosis. Mycopathologia 2008 166 5-6 267 275 10.1007/s11046‑008‑9104‑5 18478361
    [Google Scholar]
  35. Baldo A. Monod M. Mathy A. Cambier L. Bagut E.T. Defaweux V. Symoens F. Antoine N. Mignon B. Mechanisms of skin adherence and invasion by dermatophytes. Mycoses 2012 55 3 218 223 10.1111/j.1439‑0507.2011.02081.x 21831104
    [Google Scholar]
  36. Kasperova A. Kunert J. Raska M. The possible role of dermatophyte cysteine dioxygenase in keratin degradation. Med. Mycol. 2013 51 5 449 454 10.3109/13693786.2013.794310 23758130
    [Google Scholar]
  37. Aljabre S.H.M. Richardson M.D. Scott E.M. Shankland G.S. Germination of Trichophyton mentagrophytes on human stratum corneum in vitro. Med. Mycol. 1992 30 2 145 152 10.1080/02681219280000191 1588464
    [Google Scholar]
  38. Havlickova B. Czaika V.A. Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008 51 Suppl 4 2 15 10.1111/j.1439‑0507.2008.01606.x 18783559
    [Google Scholar]
  39. Weitzman I. Summerbell R.C. The dermatophytes. Clin. Microbiol. Rev. 1995 8 2 240 259 10.1128/CMR.8.2.240 7621400
    [Google Scholar]
  40. Duek L. Kaufman G. Ulman Y. Berdicevsky I. The pathogenesis of dermatophyte infections in human skin sections. J. Infect. 2004 48 2 175 180 10.1016/j.jinf.2003.09.008 14720494
    [Google Scholar]
  41. Ziółkowska G. Nowakiewicz A. Gnat S. Trościańczyk A. Zięba P. Majer Dziedzic B. Molecular identification and classification of Trichophyton mentagrophytes complex strains isolated from humans and selected animal species. Mycoses 2015 58 3 119 126 10.1111/myc.12284 25643744
    [Google Scholar]
  42. Gnat S. Nowakiewicz A. Łagowski D. Zięba P. Host- and pathogen-dependent susceptibility and predisposition to dermatophytosis. J. Med. Microbiol. 2019 68 6 823 836 10.1099/jmm.0.000982 31050630
    [Google Scholar]
  43. Moriello K.A. Coyner K. Paterson S. Mignon B. Diagnosis and treatment of dermatophytosis in dogs and cats. Vet. Dermatol. 2017 28 3 266 e68 10.1111/vde.12440 28516493
    [Google Scholar]
  44. DeBoer D.J. Moriello K.A. Development of an experimental model of Microsporum canis infection in cats. Vet. Microbiol. 1994 42 4 289 295 10.1016/0378‑1135(94)90060‑4 9133054
    [Google Scholar]
  45. Sardana K. Gupta A. Mathachan S.R. Immunopathogenesis of dermatophytoses and factors leading to recalcitrant infections. Indian Dermatol. Online J. 2021 12 3 389 399 10.4103/idoj.IDOJ_503_20 34211904
    [Google Scholar]
  46. Calderon R.A. Mackenzie D.W.R. Immunoregulation of dermatophytosis. CRC Crit. Rev. Microbiol. 1989 16 5 339 368 10.3109/10408418909104472 2651010
    [Google Scholar]
  47. Reis A.P.C. Correia F.F. Jesus T.M. Pagliari C. Sakai-Valente N.Y. Belda Júnior W. Criado P.R. Benard G. Sousa M.G.T. In situ immune response in human dermatophytosis: Possible role of Langerhans cells (CD1a+) as a risk factor for dermatophyte infection. Rev. Inst. Med. Trop. São Paulo 2019 61 e56 10.1590/s1678‑9946201961056 31618376
    [Google Scholar]
  48. Tainwala R. Sharma Y.K. Pathogenesis of dermatophytoses. Indian J. Dermatol. 2011 56 3 259 261 10.4103/0019‑5154.82476 21772583
    [Google Scholar]
  49. Verma A.H. Gaffen S.L. Dermatophyte immune memory is only skin-deep. J. Invest. Dermatol. 2019 139 3 517 519 10.1016/j.jid.2018.10.022 30797318
    [Google Scholar]
  50. Singh A. Masih A. Khurana A. Singh P.K. Gupta M. Hagen F. Meis J.F. Chowdhary A. High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene. Mycoses 2018 61 7 477 484 10.1111/myc.12772 29577447
    [Google Scholar]
  51. Calich V.L. Blotta M.H. Pulmonary paracoccidioidomycosis. Fungal Immunology Boston, MA Springer Fidel P.L. Huffnagle G.B 201 227 2005 10.1007/0‑387‑25445‑5_10
    [Google Scholar]
  52. Waldman A. Segal R. Berdicevsky I. Gilhar A. CD4 + and CD8 + T cells mediated direct cytotoxic effect against Trichophyton rubrum and Trichophyton mentagrophytes. Int. J. Dermatol. 2010 49 2 149 157 10.1111/j.1365‑4632.2009.04222.x 19968718
    [Google Scholar]
  53. Traynor T.R. Huffnagle G.B. Role of chemokines in fungal infections. Med. Mycol. 2001 39 1 41 50 10.1080/mmy.39.1.41.50 11270407
    [Google Scholar]
  54. Al Hasan M. Fitzgerald S.M. Saoudian M. Krishnaswamy G. Dermatology for the practicing allergist: Tinea pedis and its complications. Clin. Mol. Allergy 2004 2 1 5 10.1186/1476‑7961‑2‑5 15050029
    [Google Scholar]
  55. Saraiva M. O’Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010 10 3 170 181 10.1038/nri2711 20154735
    [Google Scholar]
  56. Gaffen S.L. Hernández-Santos N. Peterson A.C. IL-17 signaling in host defense against Candida albicans. Immunol. Res. 2011 50 2-3 181 187 10.1007/s12026‑011‑8226‑x 21717069
    [Google Scholar]
  57. Huppler A.R. Conti H.R. Hernández-Santos N. Darville T. Biswas P.S. Gaffen S.L. Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis. J. Immunol. 2014 192 4 1745 1752 10.4049/jimmunol.1302265 24442441
    [Google Scholar]
  58. Woodfolk J.A. Sung S.S.J. Benjamin D.C. Lee J.K. Platts-Mills T.A.E. Distinct human T cell repertoires mediate immediate and delayed-type hypersensitivity to the Trichophyton antigen, Tri r 2. J. Immunol. 2000 165 8 4379 4387 10.4049/jimmunol.165.8.4379 11035075
    [Google Scholar]
  59. Woodfolk J.A. Wheatley L.M. Piyasena R.V. Benjamin D.C. Platts-Mills T.A.E. Trichophyton antigens associated with IgE antibodies and delayed type hypersensitivity. Sequence homology to two families of serine proteinases. J. Biol. Chem. 1998 273 45 29489 29496 10.1074/jbc.273.45.29489 9792655
    [Google Scholar]
  60. Weinstein A. Berman B. Topical treatment of common superficial tinea infections. Am. Fam. Physician 2002 65 10 2095 2102 12046779
    [Google Scholar]
  61. Van Hees C. Naafs B. Common Skin Diseases in Africa: An Illustrated Guide Stichting TrodermaVan Hees 2011
    [Google Scholar]
  62. Elewski B.E. Tinea capitis: A current perspective. J. Am. Acad. Dermatol. 2000 42 1 1 20 10.1016/S0190‑9622(00)90001‑X 10607315
    [Google Scholar]
  63. Moriarty B. Hay R. Morris-Jones R. The diagnosis and management of tinea. BMJ 2012 345 jul10 1 e4380 10.1136/bmj.e4380 22782730
    [Google Scholar]
  64. Segal E. Elad D. Human and zoonotic dermatophytoses: Epidemiological aspects. Front. Microbiol. 2021 12 713532 10.3389/fmicb.2021.713532 34421872
    [Google Scholar]
  65. Kidd S. Halliday C. Ellis D. Descriptions of Medical Fungi CABI 2022 4th ed 10.1079/9781800622340.0000
    [Google Scholar]
  66. García-Agudo L. Espinosa-Ruiz J.J. Tinea capitis due to Microsporum gypseum, a rare species. Arch. Argent. Pediatr. 2018 116 2 e296 e299 29557619
    [Google Scholar]
  67. Seebacher C. Bouchara J.P. Mignon B. Updates on the epidemiology of dermatophyte infections. Mycopathologia 2008 166 5-6 335 352 10.1007/s11046‑008‑9100‑9 18478365
    [Google Scholar]
  68. White T.C. Findley K. Dawson T.L. Scheynius A. Boekhout T. Cuomo C.A. Xu J. Saunders C.W. Fungi on the skin: dermatophytes and Malassezia. Cold Spring Harb. Perspect. Med. 2014 4 8 a019802 10.1101/cshperspect.a019802 25085959
    [Google Scholar]
  69. Achterman R.R. Smith A.R. Oliver B.G. White T.C. Sequenced dermatophyte strains: Growth rate, conidiation, drug susceptibilities, and virulence in an invertebrate model. Fungal Genet. Biol. 2011 48 3 335 341 10.1016/j.fgb.2010.11.010 21145410
    [Google Scholar]
  70. Leung A.K.C. Lam J.M. Leong K.F. Hon K.L. Tinea corporis: An updated review. Drugs Context 2020 9 1 12 10.7573/dic.2020‑5‑6 32742295
    [Google Scholar]
  71. Belhadjali H. Aounallah A. Youssef M. Gorcii M. Babba H. Zili J. Tinea faciei, underrecognized because clinically misleading. 14 cases. Presse. Med. 38 9 1230 1234 2009 10.16/j.lpm.2008.10.017 19217248
    [Google Scholar]
  72. Alteras I. Sandbank M. David M. Segal R. 15-year survey of tinea faciei in the adult. Dermatology 1988 177 2 65 69 10.1159/000248519 2971583
    [Google Scholar]
  73. Gupta A.K. Summerbell R.C. Tinea capitis. Med. Mycol. 2000 38 4 255 287 10.1080/mmy.38.4.255.287 10975696
    [Google Scholar]
  74. Taghipour S. Pchelin I.M. Zarei Mahmoudabadi A. Ansari S. Katiraee F. Rafiei A. Shokohi T. Abastabar M. Taraskina A.E. Kermani F. Diba K. Nouripour-Sisakht S. Najafzadeh M.J. Pakshir K. Zomorodian K. Ahmadikia K. Rezaei-Matehkolaei A. Trichophyton mentagrophytes and T interdigitale genotypes are associated with particular geographic areas and clinical manifestations. Mycoses 2019 62 11 1084 1091 10.1111/myc.12993 31444823
    [Google Scholar]
  75. Li H. Wu S. Mao L. Lei G. Zhang L. Lu A. An L. Yang G. Abliz P. Meng G. Human pathogenic fungus Trichophyton schoenleinii activates the NLRP3 inflammasome. Protein Cell 2013 4 7 529 538 10.1007/s13238‑013‑2127‑9 23686720
    [Google Scholar]
  76. Verma S.B. Panda S. Nenoff P. Singal A. Rudramurthy S.M. Uhrlass S. Das A. Bisherwal K. Shaw D. Vasani R. The unprecedented epidemic-like scenario of dermatophytosis in India: III. Antifungal resistance and treatment options. Indian J. Dermatol. Venereol. Leprol. 2021 87 4 468 482 10.25259/IJDVL_303_20 34219433
    [Google Scholar]
  77. Uhrlaß S. Verma S.B. Gräser Y. Rezaei-Matehkolaei A. Hatami M. Schaller M. Nenoff P. Trichophyton indotineae - An emerging pathogen causing recalcitrant dermatophytoses in India and worldwide - A multidimensional perspective. J. Fungi (Basel) 2022 8 7 757 10.3390/jof8070757 35887512
    [Google Scholar]
  78. Bishnoi A. Vinay K. Dogra S. Emergence of recalcitrant dermatophytosis in India. Lancet Infect. Dis. 2018 18 3 250 251 10.1016/S1473‑3099(18)30079‑3 29485088
    [Google Scholar]
  79. Pier A.C. Smith J.M. Alexiou H. Ellis D.H. Lund A. Pritchard R.C. Animal ringworm - Its aetiology, public health significance and control. J. Med. Vet. Mycol. 32 Suppl 1 133 150 1994 10.1080/02681219480000791
    [Google Scholar]
  80. Krzyściak P. Al-Hatmi A.M.S. Ahmed S.A. Macura A.B. Rare zoonotic infection with Microsporum persicolor with literature review. Mycoses 2015 58 9 511 515 10.1111/myc.12341 26103049
    [Google Scholar]
  81. English M.P. Trichophyton persicolor infection in the field vole and pipistrelle bat. Med. Mycol. 1966 4 4 219 222 10.1080/00362176685190501 6006211
    [Google Scholar]
  82. Begum J. Kumar R. Prevalence of dermatophytosis in animals and antifungal susceptibility testing of isolated Trichophyton and Microsporum species. Trop. Anim. Health Prod. 2021 53 1 3 10.1007/s11250‑020‑02476‑3 33196912
    [Google Scholar]
  83. Veraldi S. Genovese G. Peano A. Tinea corporis caused by Trichophyton equinum in a rider and review of the literature. Infection 2018 46 1 135 137 10.1007/s15010‑017‑1067‑3 28879496
    [Google Scholar]
  84. Moretti A. Boncio L. Pasquali P. Fioretti D.P. Epidemiological aspects of dermatophyte infections in horses and cattle. Zentralbl. Veterinarmed. B. 45 4 205 208 1998 10.1111/j.1439‑0450.1998.tb00784.x
    [Google Scholar]
  85. Chermette R. Ferreiro L. Guillot J. Dermatophytoses in animals. Mycopathologia 2008 166 5-6 385 405 10.1007/s11046‑008‑9102‑7 18478363
    [Google Scholar]
  86. Durdu M. Ilkit M. Tamadon Y. Tolooe A. Rafati H. Seyedmousavi S. Topical and systemic antifungals in dermatology practice. Expert Rev. Clin. Pharmacol. 2017 10 2 225 237 10.1080/17512433.2017.1263564 27868472
    [Google Scholar]
  87. Edeoga H.O. Okwu D.E. Mbaebie B.O. Phytochemical constituents of some Nigerian medicinal plants. Afr. J. Biotechnol. 2005 4 7 685 688 10.5897/AJB2005.000‑3127
    [Google Scholar]
  88. Akinmoladun A.C. Ibukun E.O. Afor E. Obuotor E.M. Farombi E.O. Phytochemical constituent and antioxidant activity of extract from the leaves of Ocimum gratissimum. Sci. Res. Essays 2007 2 5 163 166
    [Google Scholar]
  89. Rout S.P. Choudary K.A. Kar D.M. Das L.O. Jain A. Plants in traditional medicinal system-future source of new drugs. Int. J. Pharm. Pharm. Sci. 2009 1 1 1 23
    [Google Scholar]
  90. Di Santo R. Natural products as antifungal agents against clinically relevant pathogens. Nat. Prod. Rep. 2010 27 7 1084 1098 10.1039/b914961a 20485730
    [Google Scholar]
  91. Tomishima M. Ohki H. Yamada A. Maki K. Ikeda F. Novel echinocandin antifungals. Part 1: Novel side-chain analogs of the natural product FR901379. Bioorg. Med. Chem. Lett. 2008 18 4 1474 1477 10.1016/j.bmcl.2007.12.062 18207736
    [Google Scholar]
  92. Abad M.J. Ansuategui M. Bermejo P. Active antifungal substances from natural sources. ARKIVOC 2007 7 11 6 145
    [Google Scholar]
  93. Barrett D. From natural products to clinically useful antifungals. Biochim. Biophys. Acta Mol. Basis Dis. 2002 1587 2-3 224 233 10.1016/S0925‑4439(02)00085‑6
    [Google Scholar]
  94. Taha K.F. El-hawary S.S. El-hefnawy H.M. Mabrouk M.I. Sanad R.A. El Harriry M.Y. Formulation and assessment of a herbal hair cream against certain dermatophytes. Int. J. Pharm. Pharm. Sci. 2016 167 173
    [Google Scholar]
  95. Mastan A. Anti-fungal potency of some Unani drugs in the treatmentofdermatophytoses (Qūba). TMR Integr. Med. 2021 5 e21004 10.12032/TMRIM202105004
    [Google Scholar]
  96. Mudhaliyar M. Siddha Materia Medica Chennai, India Indian medicine and Homoeopathy 2003
    [Google Scholar]
  97. Samuel J.K. Andrews B. Jebashree H.S. In vitro evaluation of the antifungal activity of Allium sativum bulb extract against Trichophyton rubrum, a human skin pathogen. World J. Microbiol. Biotechnol. 2000 16 7 617 620 10.1023/A:1008972016316
    [Google Scholar]
  98. Adejumo T.O. Bamidele B.S. Control of dermatophyte-causing agents (Trichophyton mentagrophytes and Trichophyton rubrum) using six medicinal plants. J. Med. Plants Res. 2009 3 11 906 913
    [Google Scholar]
  99. Kisangau D.P. Herrmann T.M. Utilization and conservation of medicinal plants used for primary health care in Makueni district, Kenya. Int. J. Biodivers. Sci. Manag. 2007 3 3 184 192 10.1080/17451590709618172
    [Google Scholar]
  100. Afolayan A.J. Grierson D.S. Mbeng W.O. Ethnobotanical survey of medicinal plants used in the management of skin disorders among the Xhosa communities of the Amathole District, Eastern Cape, South Africa. J. Ethnopharmacol. 2014 153 1 220 232 10.1016/j.jep.2014.02.023 24583071
    [Google Scholar]
  101. Maroyi A. Acacia karroo Hayne: Ethnomedicinal uses, phytochemistry and pharmacology of an important medicinal plant in southern Africa. Asian Pac. J. Trop. Med. 2017 10 4 351 360 10.1016/j.apjtm.2017.03.021 28552105
    [Google Scholar]
  102. Mishra K.K. Dhongade H.J. Banarase N.B. Rajput D.S. Evaluation of antifungal activity of roots of Achyranthes aspera for ring worm infection. Eur. J. Pharm. Med. Res. 2012 3 2 318 320
    [Google Scholar]
  103. Farazilah F. Kunsah B. Arimurti A.R. Effect of peel extract and crown of pineapple (Ananas comosus L. Merr) on the growth of trichophytonrubrum fungus. Int. Conf. Med. Lab. Technol. 2 1 2022 24 29
    [Google Scholar]
  104. Motsei M.L. Lindsey K.L. van Staden J. Jäger A.K. Screening of traditionally used South African plants for antifungal activity against Candida albicans. J. Ethnopharmacol. 2003 86 2-3 235 241 10.1016/S0378‑8741(03)00082‑5 12738093
    [Google Scholar]
  105. Ghuman S. Ncube B. Finnie J.F. McGaw L.J. Coopoosamy R.M. Van Staden J. Antimicrobial activity, phenolic content, and cytotoxicity of medicinal plant extracts used for treating dermatological diseases and wound healing in KwaZulu-Natal, South Africa. Front. Pharmacol. 2016 7 320 10.3389/fphar.2016.00320 27746731
    [Google Scholar]
  106. Shahidi Bonjar G.H. Aghighi S. Karimi Nik A. Antibacterial and antifungal survey in plants used in indigenous herbal-medicine of south east regions of Iran. J. Biol. Sci. 2004 4 3 405 412 10.3923/jbs.2004.405.412
    [Google Scholar]
  107. Omran S. Alsamarai A. Razzzaq F. Therapeutic efficacy of some extracts of hot pepper fruits (Capsicum annuum) and Sumac seeds (Rhus coriaria) on the growth of some isolated dermatophytes species. Int. J. Med. Sci. 2018 1 3 52 62 10.32441/ijms.v1i3.102
    [Google Scholar]
  108. Bhat N.A. Bhadwaj A. Tiwari B.K. Anti-dermatophytic activity Of Catharanthus roseus L.(Leaves). Int J Inno Res Adv Stud 2017 4 4 161 165
    [Google Scholar]
  109. Adel A. Elnaggar M. Al-Sayed E. Rabeh M. Secondary metabolites from Carica papaya, and its biological activities: A comprehensive review. Arch. Pharm. Sci. Ain Shams Univ. 2021 5 2 331 353 10.21608/aps.2021.106355.1073
    [Google Scholar]
  110. Singh JP Efficacy of lesser known homoeopathic drugs on skin disorders. Indian J. Res. Homoeopathy 25 3&4 2003
    [Google Scholar]
  111. Bhat P. Hegde G.R. Hegde G. Mulgund G.S. Ethnomedicinal plants to cure skin diseases—An account of the traditional knowledge in the coastal parts of Central Western Ghats, Karnataka, India. J. Ethnopharmacol. 2014 151 1 493 502 10.1016/j.jep.2013.10.062 24239890
    [Google Scholar]
  112. Njoroge G.N. Bussmann R.W. Ethnotherapeautic management of skin diseases among the Kikuyus of Central Kenya. J. Ethnopharmacol. 2007 111 2 303 307 10.1016/j.jep.2006.11.025 17207950
    [Google Scholar]
  113. Imanirampa L. Alele P.E. Antifungal activity of Cleome gynandra L. aerial parts for topical treatment of Tinea capitis: An in vitro evaluation. BMC Complement. Altern. Med. 2016 16 1 194 10.1186/s12906‑016‑1187‑9 27391957
    [Google Scholar]
  114. Mabona U. Viljoen A. Shikanga E. Marston A. Van Vuuren S. Antimicrobial activity of southern African medicinal plants with dermatological relevance: From an ethnopharmacological screening approach, to combination studies and the isolation of a bioactive compound. J. Ethnopharmacol. 2013 148 1 45 55 10.1016/j.jep.2013.03.056 23545456
    [Google Scholar]
  115. Lau K.M. Fu L.H. Cheng L. Wong C.W. Wong Y.L. Lau C.P. Han S.Q.B. Chan P.K.S. Fung K.P. Lau C.B.S. Hui M. Leung P.C. Two antifungal components isolated from Fructus Psoraleae and Folium Eucalypti Globuli by bioassay-guided purification. Am. J. Chin. Med. 2010 38 5 1005 1014 10.1142/S0192415X10008421 20821830
    [Google Scholar]
  116. Shai L.J. McGaw L.J. Masoko P. Eloff J.N. Antifungal and antibacterial activity of seven traditionally used South African plant species active against Candida albicans. S. Afr. J. Bot. 2008 74 4 677 684 10.1016/j.sajb.2008.04.003
    [Google Scholar]
  117. Arkhipov A. Sirdaarta J. Rayan P. McDonnell P.A. Cock I.E. An examination of the antibacterial, antifungal, anti-Giardial and anticancer properties of Kigelia africana fruit extracts. Pharmacogn. Commun. 2014 4 3
    [Google Scholar]
  118. Nciki S. Vuuren S. van Eyk A. de Wet H. Plants used to treat skin diseases in northern Maputaland, South Africa: Antimicrobial activity and in vitro permeability studies. Pharm. Biol. 2016 54 11 2420 2436 10.3109/13880209.2016.1158287 27137350
    [Google Scholar]
  119. Bello R.Y. Antifungal activity of henna leaves (Lawsonia inermis L.) against Trichophyton rubrum and Trichophyton interdigitale. Int. J. Res. Rev. 2020 7 11 314 320
    [Google Scholar]
  120. Asong J.A. Ndhlovu P.T. Khosana N.S. Aremu A.O. Otang-Mbeng W. Medicinal plants used for skin-related diseases among the Batswanas in Ngaka Modiri Molema District Municipality, South Africa. S. Afr. J. Bot. 2019 126 11 20 10.1016/j.sajb.2019.05.002
    [Google Scholar]
  121. Welder W.M. Melaleuca alternifolia Australian Tea Tree oil as an effective antifungal agent topically for Tinea unguium (onychomycosis). J. Phytopharmacol. 2020 9 6 419 422 10.31254/phyto.2020.9606
    [Google Scholar]
  122. Nwachukwu I. Antifungal activities and phytochemical constituents of nicotiana tabacum leaf extracts on selected dermatophytes. Nijerial J Microbiol 2017 31 2 3871 3875
    [Google Scholar]
  123. Koroishi A.M. Foss S.R. Cortez D.A.G. Ueda-Nakamura T. Nakamura C.V. Dias Filho B.P. In vitro antifungal activity of extracts and neolignans from Piper regnellii against dermatophytes. J. Ethnopharmacol. 2008 117 2 270 277 10.1016/j.jep.2008.01.039 18394835
    [Google Scholar]
  124. Sheehan D.J. Hitchcock C.A. Sibley C.M. Current and emerging azole antifungal agents. Clin. Microbiol. Rev. 1999 12 1 40 79 10.1128/CMR.12.1.40 9880474
    [Google Scholar]
  125. Cauwenbergh G. Degreef H. Heykants J. Woestenborghs R. Van Rooy P. Haeverans K. Pharmacokinetic profile of orally administered itraconazole in human skin. J. Am. Acad. Dermatol. 1988 18 2 263 268 10.1016/S0190‑9622(88)70037‑7 2831254
    [Google Scholar]
  126. Arora P. Sardana K. Mahajan K. Intracutaneous pharmacokinetics of oral antifungals and their relevance in recalcitrant cutaneous dermatophytosis: Time to revisit basics. Indian J. Dermatol. Venereol. Leprol. 2017 83 6 730 732 10.4103/ijdvl.IJDVL_1012_16 28936991
    [Google Scholar]
  127. Bao Y. Wan Z. Li R. In vitro antifungal activity of micafungin and caspofungin against dermatophytes isolated from China. Mycopathologia 2013 175 1-2 141 145 10.1007/s11046‑012‑9571‑6 22983900
    [Google Scholar]
  128. Suchil P. Montero Gei F. Robles M. Perera-Ramírez A. Welsh O. Male O. Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasis. Clin. Exp. Dermatol. 1992 17 6 397 401 10.1111/j.1365‑2230.1992.tb00246.x 1486705
    [Google Scholar]
  129. Greer D.L. Successful treatment of tinea capitis with 2% ketoconazole shampoo. Int. J. Dermatol. 2000 39 4 302 304 10.1046/j.1365‑4362.2000.00885.x 10809984
    [Google Scholar]
  130. Jegasothy B.V. Pakes G.E. Oxiconazole nitrate: Pharmacology, efficacy, and safety of a new imidazole antifungal agent. Clin. Ther. 1991 13 1 126 141 2029718
    [Google Scholar]
  131. Gupta A.K. Foley K.A. Versteeg S.G. New antifungal agents and new formulations against dermatophytes. Mycopathologia 2017 182 1-2 127 141 10.1007/s11046‑016‑0045‑0 27502503
    [Google Scholar]
  132. Elewski B.E. Vlahovic T.C. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials. J. Drugs Dermatol. 2014 13 7 803 808 25007362
    [Google Scholar]
  133. Khanna D. Bharti S. Luliconazole for the treatment of fungal infections: An evidence-based review. Core Evid. 2014 9 113 124 10.2147/CE.S49629 25285056
    [Google Scholar]
  134. Giri V.P. Sertaconazole nitrate 2% cream for the treatment of tinea pedis. Nat J Lab Med 2016 5 1 5
    [Google Scholar]
  135. Li R.Y. Wang A.P. Xu J.H. Xi L.Y. Fu M.H. Zhu M. Xu M.L. Li X.Q. Lai W. Liu W.D. Lu X.Y. Gong Z.Q. Efficacy and safety of 1 % terbinafine film-forming solution in Chinese patients with tinea pedis: A randomized, double-blind, placebo-controlled, multicenter, parallel-group study. Clin. Drug Investig. 2014 34 3 223 230 10.1007/s40261‑014‑0171‑8 24477462
    [Google Scholar]
  136. Gupta A.K. Ryder J.E. Cooper E.A. Naftifine: A review. J. Cutan. Med. Surg. 2008 12 2 51 58 10.2310/7750.2008.06009 18346400
    [Google Scholar]
  137. Stein Gold L.F. Vlahovic T. Verma A. Olayinka B. Fleischer A.B. Naftifine hydrochloride Gel 2%: an effective topical treatment for moccasin-type tinea pedis. J. Drugs Dermatol. 2015 14 10 1138 1144 26461826
    [Google Scholar]
  138. Zhang A.Y. Camp W.L. Elewski B.E. Advances in topical and systemic antifungals. Dermatol. Clin. 2007 25 2 165 183, vi 10.1016/j.det.2007.01.002 17430754
    [Google Scholar]
  139. Sheikh S. Ahmad A. Ali S.M. Paithankar M. Barkate H. Raval R.C. Shah K. Bhavsar B.A. Radha K.R. Jayaraman A.M. Topical delivery of lipid based amphotericin B gel in the treatment of fungal infection: A clinical efficacy, safety and tolerability study in patients. J. Clin. Exp. Dermatol. Res. 2014 5 248 2
    [Google Scholar]
  140. Gupta A.K. Skinner A.R. Ciclopirox for the treatment of superficial fungal infections: A review. Int. J. Dermatol. 2003 42 Suppl 1 3 9 10.1046/j.1365‑4362.42.s1.2.x 12895181
    [Google Scholar]
  141. Bardal S.K. Waechter J.E. Martin D.S. Chapter 18 - Infectious diseases. Applied pharmacology. Elsevier 2011 233 291 10.1016/B978‑1‑4377‑0310‑8.00018‑X
    [Google Scholar]
  142. Jordá T. Puig S. Regulation of ergosterol biosynthesis in Saccharomyces cerevisiae. Genes (Basel) 2020 11 7 795 10.3390/genes11070795 32679672
    [Google Scholar]
  143. Develoux M. Griseofulvin. Ann. Dermatol. Venereol. 2001 128 12 1317 1325 11908134
    [Google Scholar]
  144. Dwivedi M. In vitro inhibition of Tinea corporis from various extracts of aloe vera and Azadirachta indica. Acta Sci. Microbiol. 2018 1 9 15 23
    [Google Scholar]
  145. Patil P.A. Kandle H.S. Shelke G.S. Sathe P.T. Rohile V.Y. Formulation and evaluation of nanoemulsion comprising of berberis aristata and croton tiglium as effective treatment for tinea capitis fungal infection. World J. Pharm. Res. 2021 10 14 965 974
    [Google Scholar]
  146. Nautiyal O.H. Anti-fungal activity of Nardostachys jatamansi essential oil beneficial for treating (dermatophytosis) ringworm. J. Nat. Prod. 2013 9 241
    [Google Scholar]
  147. Bhadauria S. Kumar P. Broad spectrum antidermatophytic drug for the control of tinea infection in human beings. Mycoses 2012 55 4 339 343 10.1111/j.1439‑0507.2011.02120.x 21929713
    [Google Scholar]
  148. Rajak P. Patra E. Karmakar A. Bhuyan B. Xanthium strumarium L. extract loaded phyto-niosome gel: Development and in vitro assessment for the treatment of Tinea corporis. Biores. Interface in Appl. Chem. 2023 13 3 1 15
    [Google Scholar]
  149. Moghimipour E. Ameri A. Saudatzadeh A. Salimi A. Siahpoosh A. Formulation of an anti-dermatophyte cream from hydro-alcoholic extract of eucalyptus camaldulensis leaves. Jundishapur J. Nat. Pharm. Prod. 2009 4 1 32 40
    [Google Scholar]
  150. Genatrika E. Sundhani E. Oktaviana M. Gel potential of red onion (Allium cepa L.) ethanol extract as antifungal cause tinea pedis. J. Pharm. Bioallied Sci. 2020 12 Suppl 2 S733 S736 10.4103/jpbs.JPBS_256_19 33828369
    [Google Scholar]
  151. Kaushik K. Sharma R.B. Sharma A. Agarwal S. Formulation and evaluation of antifungal activity of gel of crude methanolic extract of leaves of Ipomoea carnea Jacq. J. Res. Pharm. 2020 24 3 368 379 10.35333/jrp.2020.159
    [Google Scholar]
  152. Fawehinmi A.B. Oyedeji F.O. Evaluation of formulated anti-dermatophyte creams from ethanol extract of mitracarpus villosus leaves. Int. J. Biochem. Res. Rev. 2020 29 9 1 12 10.9734/ijbcrr/2020/v29i930219
    [Google Scholar]
  153. Anti fungal foot cream. Available from: https://azanicare.com/products/anti-fungal-foot-cream(Accessed on: Feb.28,2023)
  154. Facts about tinea capitis infection. Available from: https://www.dovemed.com/slideshows/facts-about-tinea-capitis-infection(Accessed on: Feb.28,2023)
  155. Terbinaforce cream. Available from: https://www.pulseplus.in/product/terbinaforce-cream-pc-35581?gclid=EAIaIQobChMIsM-f2vm3_QIVQR0rCh1npg8sEAYYBSABEgLHm_D_BwE(Accessed on: Feb.28,2023)
  156. Grifulvin V. 2021 Available from: https://www.rxlist.com/grifulvin-v-drug.htm(Accessed on: Feb.28,2023)
  157. Xolegel. 2021 Available from: https://www.rxlist.com/xolegel-drug.htm(Accessed on: Feb.28,2023)
  158. Lamisil athelete's foot antifungal cream, full prescription strength for itching, burning, cracking, and scaling, 1 ounce (pack of 2). Available from: https://www.amazon.com/dp/B01IN5FCZ6/?tag=cb-263156-20(Accessed on: Feb.28,2023)
  159. Ring guard antifungal medicated cream, 12 gm. Available from: https://www.apollopharmacy.in/otc/ring-guard-cream-12g(Accessed on: Feb.28,2023)
  160. Lotrimin® AF athlete's foot powder spray. Available from: https://www.lotrimin.com/our-products/athlete-powder-spray#:~:text=Clinically%20proven%20to%20cure%20most,commonly%20known%20as%20athlete's%20foot(Accessed on: March 3, 2023)
  161. Ayurvedic anti-fungal cream. Available from: https://www.swastikayurveda.co.in/product/swiss-itch-cream/(Accessed on: March 3, 2023)
  162. Canesten® dermatological spray. Available from: https://www.canesten.co.uk/discover-canesten-products/canesten-dermatological-spray#:~:text=%C2%AE%20Dermatological%20Spray-,Canesten%C2%AE%20Dermatological%20Spray,the%20fungi%20and%20soothes%20irritation(Accessed on: March 3, 2023)
  163. Terbicip 1% spray 30ml. Available from: https://www.netmeds.com/prescriptions/terbicip-1-spray-30ml(Accessed on: March 3, 2023)
  164. Strobel G.A. Method and composition for treating ringworm on biotic and abiotic surfaces. US Patent 20230173004A1 2023
  165. Thompson W. US Patent 20220062201A1 Compositions and methods of treatment for tinea pedis. 2022
  166. Hazot Y. Feiman J.N.B. Tamarkin D. Schuz D. Caley S.M. Hardas B. Hydroalcoholic foam formulations of naftifine. US Patent 20190282501A1 2019
  167. Wright K.W. Method for treating and preventing recurrent interdigital tinea pedis (athlete's foot) disease. US Patent 20160287529A1 2016
  168. Boegli C.J. Topical antifungal composition. US Patent 8449926B2 2013
  169. Toshimitsu A. Fujita N. Kogure T. Adhesive patch for treatment of tinea unguium. US Patent 8574621B2 2013
  170. Goldstein J.A. Rothman M. Lo W.Y. 2012 Antifungal formulations. US patent 20120165302A1
  171. Hohenstein K. Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues. US patent 20110160166A1 2011
  172. Chen J. Pharmaceutical formulation for treating tinea of feet and hands and preparation thereof. US Patent 8158159B2 2012
  173. Chauhan V.S. Satyan K.S. Kadam K.P. Herbal composition for Tinea infection. US Patent 7635493B2 2009
/content/journals/raaidd/10.2174/0127724344305611241113174748
Loading
Comprehensive Review on Tinea Infection Therapies: Allopathic and Herbal Approaches for Dermatophytosis
Bentham Science Publishers ; https://doi.org/10.2174/0127724344305611241113174748
/content/journals/raaidd/10.2174/0127724344305611241113174748
/content/journals/raaidd/10.2174/0127724344305611241113174748
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: Tinea pedis ; Tinea capitis ; Dermatophytosis ; Trichophyton rubrum ; Ringworm ; Tinea infection

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test